Article

Interconnecting ADC Structure with Tumor Cell Biology with Multimodal Learning

2026-05-27

Abstract excerpt

Antibody-drug conjugates (ADCs) represent a significant advancement in cancer therapy, yet their development remains constrained by high attrition rates driven by an incomplete understanding of how ADC chemical design interconnects with tumor biology. Compounding this challenge, the field has converged on a narrow set of redundant structural components, and current linker-payload systems that do not share a single...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2814a7b-d865-5255-a740-7c4f6c92c52b
DOI: 10.64898/2026.05.22.727320

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Interconnecting ADC Structure with Tumor Cell Biology with Multimodal LearningDOI 10.64898/2026.05.22.727320Read

Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis.Semantic proximity Read

The Target Atlas for Antibody-Drug Conjugates across Solid CancersSemantic proximity Read

Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid TumorsSemantic proximity Read

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read

Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugsSemantic proximity Read

AI-based Cancer Models for Prediction of Antibody-Drug Conjugate (ADC) Response in OncologySemantic proximity Read

High-Throughput Machine Learning-Aided Antibody Discovery for Cell Surface AntigensSemantic proximity Read

From Small Molecules to Degraders and AI: Contemporary Trends and Future Directions in Anticancer Drug DiscoverySemantic proximity Read

From Small Molecules to Degraders and AI: Contemporary Trends and Future Directions in Anticancer Drug DiscoverySemantic proximity Read

Therapeutic Monoclonal Antibodies Repurposing in Oncology via IMGT/mAb-KG EmbeddingsSemantic proximity Read

ImmunoStruct: a multimodal neural network framework for immunogenicity prediction from peptide-MHC sequence, structure, and biochemical propertiesSemantic proximity Read

Intrinsic physicochemical profile of marketed antibody-based biotherapeuticsSemantic proximity Read